Kotak Healthcare Fund Direct Growth

Kotak Healthcare Fund Direct Growth

Equity

Direct

Sector - Healthcare

NAV as on 21-03-2025

₹ 13.26

1.4%

1D

Inception Returns

23.3%

/yr

About Kotak Healthcare Fund Direct Growth

Kotak Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 December, 2023. The fund is managed by Shibani Kurian, Abhishek Bisen. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Kotak Healthcare Fund Direct Growth has ₹380 Cr worth of assets under management (AUM) as on Jan 2025 and is less than category average.
  2. The fund has an expense ratio 0.8.

Returns

Kotak Healthcare Fund Direct Growth has given a CAGR return of 23.30% since inception. Over the last 1 year the fund has given a CAGR return of 19.34%.

Holdings

Kotak Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Max Healthcare Institute Ltd Ordinary Shares, Divi's Laboratories Ltd, J.B. Chemicals & Pharmaceuticals Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of Kotak Healthcare Fund Direct Growth

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. Kotak Healthcare Fund Direct Growth has no lock in period.

Historical NAV & Returns

Absolute

zero opening, trading, fund transfer fee
853 people have invested ₹ 20.5L in Kotak Healthcare Fund Direct Growth in the last three months

Kotak Healthcare Fund Direct Growth Overview

Expense ratio0.78%
Benchmark
S&P BSE Healthcare PR
AUM₹380 Cr
Inception Date11 December, 2023
Min Lumpsum/SIP₹100/₹100
Exit Load
0.5%
Lock InNo Lock-in
TurnOver
4.89%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

Trailing Returns

as on (21-Mar-25)

Period
Kotak Healthcare Fund Direct Growth
Nifty 500
sector - healthcare
1M
3.3%
2.8%
2.3%
3M
-7.7%
-4.7%
-5.8%
6M
-7.5%
-12.1%
-6.3%
1Y
19.3%
6.9%
21.3%

Fund Distribution

as on (31-Jan-25)

  • Equity 98.7%

  • Debt & Cash 1.3%

Large cap
39.5%

Mid cap
29.6%

Small cap
27.8%

Sector Allocation

Feb'25

Jan'25

Dec'24

Health
97.4%
Basic Materials
2.6%
All changes are between Nov'24 and Jan'25
Dec'24
Nov'24
Fund Returns
3.71%
0.63%
Nifty 500
-2.02%
-0.60%
Parameters
Feb'25
Jan'25
Dec'24
AUM
₹ 379.9 Cr
₹ 439 Cr
₹ 418.7 Cr
  • AUM of the fund stands at 379.9 Cr as of Feb'25
  • AUM decreased by 59.2 Cr between Feb'25 and Jan'25
Top Stocks bought last month
Sun Pharmaceuticals Industries Ltd's allocation increased from 14.61% to 15.94%
Sun Pharmaceuticals Industries Ltd's allocation increased from 14.61% to 15.94%
Ami Organics Ltd's allocation increased from 2.2% to 2.58%
Ami Organics Ltd's allocation increased from 2.2% to 2.58%
Krishna Institute of Medical Sciences Ltd's allocation increased from 2.03% to 2.2%
Krishna Institute of Medical Sciences Ltd's allocation increased from 2.03% to 2.2%
Top Stocks sold last month
Divi's Laboratories Ltd's allocation decreased from 5 % to 4.83 %
Divi's Laboratories Ltd's allocation decreased from 5 % to 4.83 %
Max Healthcare Institute Ltd Ordinary Shares's allocation decreased from 4.29 % to 4.26 %
Max Healthcare Institute Ltd Ordinary Shares's allocation decreased from 4.29 % to 4.26 %
Dr Reddy's Laboratories Ltd's allocation decreased from 4.2 % to 3.66 %
Dr Reddy's Laboratories Ltd's allocation decreased from 4.2 % to 3.66 %
Small Cap allocation has gone down from 31.7% to 27.8%
Small Cap allocation has gone down from 31.7% to 27.8%
Mid Cap allocation has gone up from 27% to 29.6%
Mid Cap allocation has gone up from 27% to 29.6%
Large Cap allocation has gone up from 37.1% to 39.5%
Large Cap allocation has gone up from 37.1% to 39.5%
Cash allocation has gone down from 1.8% to 1.3%
Cash allocation has gone down from 1.8% to 1.3%

Top 2 Sectors in February were Health, Basic Materials

Feb'25
Health
97%
Basic Materials
3%
Jan'25
Health
97%
Basic Materials
3%
  • Gainers

  • Losers

Top Growth Drivers
1M Return
Hikal Ltd
Hikal Ltd
13.5%
Fund
Jan'25
Dec'24
Nov'24
No of Holdings
34
32
30
Top 5 Company Concentration
35.2%
34%
35.5%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (15.9%)
Sun Pharmaceuticals Industries Ltd (14.6%)
Sun Pharmaceuticals Industries Ltd (14.8%)
No of Sectors
2
2
2
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (97.4%)
Health (97.8%)
Health (97.7%)
Loading...
We are taking more time than usual
Shibani Kurian
Shibani Kurian
Fund Manager of Kotak Healthcare Fund Direct Growth, since 11 December 2023
Abhishek Bisen
Abhishek Bisen
Fund Manager of Kotak Healthcare Fund Direct Growth, since 11 December 2023
Fund House
Kotak Mahindra Asset Management Co Ltd
Total Schemes
Total AUM
₹4.84L Cr
as on 31-Jan-2025
Address
Kotak Mahindra Asset management Company Limited,2nd Floor, 12-BKC, Plot No C-12,G Block, BKC, Bandra (East),Mumbai - 400 051
Phone
91-22-40930000
Website
fundaccops@kotakmutual.com

Kotak Healthcare Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 23.3% since inception which is more than its category average return of 17.27%
Fund Allocations

Fund Allocations

This fund has an allocation of 98.67% in Equity, 0% in Debt and 1.33% in Cash related instruments
AUM size ₹380 Cr

AUM size ₹380 Cr

This fund has AUM of ₹380 Cr which is less than its category average of ₹ 1725 Cr
Expense Ratio 0.78%

Expense Ratio 0.78%

This fund has an expense ratio of 0.78% which is less than its category average expense ratio of 1.44%

Frequently Asked Questions for Kotak Healthcare Fund Direct Growth

The current NAV of Kotak Healthcare Fund Direct Growth is ₹13.26 as on 21-Mar-2025.
Existing (Absolute + CAGR) as on 21-Mar-2025.
Kotak Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
3.27%
3.27%
6 Month Returns
-7.54%
-7.54%
1 Year Returns
19.34%
19.34%
3 Years Returns
0%
0%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.78% as on February 2025
₹380 Cr as on February 2025
Sun Pharmaceuticals Industries Ltd(17.83%), Cipla Ltd(6.37%), Max Healthcare Institute Ltd Ordinary Shares(6.05%), Divi's Laboratories Ltd(5.19%), J.B. Chemicals & Pharmaceuticals Ltd(4.11%) as on February 2025
The alpha ratio for the Kotak Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Kotak Healthcare Fund Direct Growth
-2.55
-
-
As on February 2025
The alpha for Kotak Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Kotak Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Kotak Healthcare Fund Direct Growth
1.05
-
-
As on February 2025
The Beta for Kotak Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Kotak Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Kotak Healthcare Fund Direct Growth
0.05
-
-
As on February 2025
The sharpe ratio for Kotak Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Kotak Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Kotak Healthcare Fund Direct Growth
19.69
-
-
As on February 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Shibani Kurian, Abhishek Bisen are the fund managers of Kotak Healthcare Fund Direct Growth
The Exit load of Kotak Healthcare Fund Direct Growth is 0.5%